{"id":302489,"date":"2020-09-18T11:47:02","date_gmt":"2020-09-18T09:47:02","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=302489"},"modified":"2020-09-18T23:23:58","modified_gmt":"2020-09-18T21:23:58","slug":"odobrena-upotreba-lijeka-koronavir","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2020\/09\/18\/odobrena-upotreba-lijeka-koronavir\/","title":{"rendered":"Odobrena upotreba lijeka &#8216;koronavir&#8217;"},"content":{"rendered":"<p>Koronavir se proizvodi u fabrici R-farma u \u0408aroslavu.<\/p>\n<p>Kompanija je saop\u0161tila da \u0107e lijek biti dostupan u apotekama.<\/p>\n<p>Od slede\u0107e nedjelje u apotekama \u0107e se pojaviti drugi lijek Areplivir, koji proizvodi kompanija Promomed, prenosi TASS.<\/p>\n<p>R-farm je objasnila da je cilj lijeka minimiziranje rizika od razvoja komplikacija usljed virusa korona. U studiji u kojoj je u\u010destvovalo 168 ljudi zara\u017eenih kovid-19, vi\u0161e od polovine pacijenata koji su uzimali Koronavir pokazalo je klini\u010dko pobolj\u0161anje nakon sedam dana.<\/p>\n<p>Ova cifra bila je jedan i po puta ve\u0107a od broja oporavka u grupi za pore\u0111enje, u kojoj lijek nije kori\u0161\u0107en, saop\u0161tila je kompanija.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ruska kompanija R-farm je saop\u0161tila danas da je njen lijek koronavir odobren za lije\u010denje bla\u017eih i umjerenih slu\u010dajeva oboljenja kovid 19.<\/p>\n","protected":false},"author":1,"featured_media":302490,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-302489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/302489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=302489"}],"version-history":[{"count":2,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/302489\/revisions"}],"predecessor-version":[{"id":302570,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/302489\/revisions\/302570"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/302490"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=302489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=302489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=302489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}